ESG

New data reveals a slight drop in Tennessee's youth suicide rates, yet the crisis persists as a leading cause of death, sparking urgent calls for action.

A landmark partnership is scaling a 'one-drug, many-diseases' therapy, revealing how logistics, not just labs, are key to the future of medicine.

As elephant Tina faces a life-threatening illness, Samuel L. Jackson pressures the Tulsa Zoo for her and Billy's release to a sanctuary.

Dr. Murad Alam begins his presidency of the American Academy of Dermatology, bringing deep policy and research expertise to lead the field's challenges.

Independent firm FPA is nominated for a top Morningstar award alongside PIMCO and Vanguard, highlighting its rare focus on investor returns over asset size.

After a transformative year, PRF Technologies ditches its old model for a bold new strategy in AI-driven solar analytics and advanced ocular healthcare.

A new clinical study compares a powered prosthetic knee against current tech, promising to reduce effort and revolutionize mobility for amputees.

Allspring's closed-end funds offer tempting yields, but tiny shifts in their monthly payouts reveal a complex story of risk, return, and capital erosion.

In a major industry shift, ASTM International and the British Standards Institution are centralizing global standards on one platform, reshaping engineering.

Hyundai, Genesis, and Kia secured 16 top safety ratings, including 15 TSP+ awards, showcasing their leadership under the IIHS's toughest criteria yet.

LM Funding reports higher revenue and record Bitcoin mining but a staggering $17.9M Q4 loss reveals the harsh reality of crypto market swings.

The company is entering the high-stakes mineral recycling race with new tech, but recent financial warnings cast a shadow on its ambitious green strategy.

A landmark partnership aims to tap Australia's vast Beetaloo gas reserves for domestic use and LNG export, igniting both economic hopes and fierce opposition.

The pharma giant's acquisition of Excellergy and its first-in-class Exl-111 could revolutionize treatment for millions with severe, debilitating allergies.

Trooly.AI's new platform uses AI agents to conduct 45-minute user interviews, but its 'Empathy Engine' raises new questions about tech and ethics.

From Taiwan to the world, Gogoro's battery swapping network is reshaping urban transport. Can its proven model solve Asia's mobility and pollution woes?

Agenus prepares a crucial update on its BOT+BAL immunotherapy, a potential breakthrough for cancers resistant to current treatments. What will they reveal?

EnerSys will unveil its strategic framework and technology roadmap, outlining its plan to navigate the energy transition and capitalize on market growth.

A multi-billion dollar tender for Argentina's main trade artery pits a US-backed group against a rival with alleged hidden ties to Chinese state firms.

At a key investor conference, Renibus is pitching its two Phase 3 drugs, including one with a strategic pivot after a challenging trial result.